Table 4.
Meta-Regression for Diagnostic Odds Ratio of Each Measurement
| Variable | FIB-4 for AF | NFS for AF | |||
|---|---|---|---|---|---|
| Coefficient (95% CI) | p-value | Coefficient (95% CI) | p-value | ||
| Mean age, yr | 0.063 (0.022 to 0.104) | 0.002 | 0.095 (0.048 to 0.143) | <0.001 | |
| Proportion of male, % | –0.019 (–0.037 to –0.001) | 0.034 | –0.022 (–0.043 to –0.001) | 0.040 | |
| DM, % | 0.005 (–0.011 to 0.021) | 0.561 | 0.013 (–0.001 to 0.028) | 0.065 | |
| HTN, % | 0.028 (–0.001 to 0.045) | 0.055 | 0.021 (–0.003 to 0.046) | 0.089 | |
| Dyslipidemia, % | –0.009 (–0.067 to 0.048) | 0.747 | 0.005 (–0.028 to 0.039) | 0.758 | |
| Mean BMI, kg/m2 | 0.004 (–0.086 to 0.095) | 0.919 | 0.062 (–0.032 to 0.156) | 0.196 | |
| Mean waist, cm | –0.009 (–0.075 to 0.056) | 0.774 | 0.001 (–0.070 to 0.071) | 0.997 | |
| Mean AST | –0.020 (–0.041 to 0.001) | 0.060 | –0.023 (–0.047 to 0.001) | 0.055 | |
| Mean ALT | –0.014 (–0.026 to –0.002) | 0.017 | –0.018 (–0.032 to –0.005) | 0.007 | |
FIB-4, fibrosis-4; AF, advanced fibrosis; NFS, nonalcoholic fatty liver disease (NAFLD) fibrosis score; CI, confidence interval; DM, diabetes mellitus; HTN, hypertension; BMI, body mass index; AST, aspartate aminotransferase; ALT, alanine aminotransferase.